Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children.
Latest Information Update: 10 Mar 2025
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
Most Recent Events
- 05 Mar 2025 Planned End Date changed from 24 Feb 2025 to 31 Aug 2025.
- 05 Mar 2025 Planned primary completion date changed from 24 Feb 2025 to 31 Aug 2025.
- 22 Apr 2024 New trial record